King Bio initiated the recall after discovering a small amount of products tested positive for microbial contamination.
The children’s medications are intended to treat a range of common illnesses, such as fever, cough and ear aches. King Bio produced the recalled products between August 2017 and April 2018. They were shipped to distributors and retail stores nationwide between August 2017 and July 2018.
King Bio sent letters to customers and distributors notifying them of the recall and is arranging for the return and replacement of affected medicines.
No illnesses or illnesses have been reported.
More articles on Pharmacy:
6 things to know about the EpiPen shortage
The No. 1 issue for biopharma: Public distrust
Medicare could have saved $925M by swapping brand-name combo drugs for generics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
